Lithium Chlorid

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lithium Chlorid

What is Lithium Chlorid? (Composition: Lisinopril)

Property Description
Active ingredient Lisinopril
Form Oral tablet, Oral solution
Pharmacological class Angiotensin-Converting Enzyme (ACE) Inhibitor
General purpose Helps manage systemic vascular resistance
Origin Synthetic peptide derivative

The drug entity designated as Lithium Chlorid contains the active pharmaceutical ingredient Lisinopril, a compound used to influence the cardiovascular system. It is classified as an Angiotensin-Converting Enzyme (ACE) Inhibitor, representing a major class of synthetic medications designed to help regulate blood pressure and fluid balance. Lisinopril is a widely used therapy in cardiovascular medicine.


What Type of Medicine is Lisinopril?

Lisinopril is fundamentally a synthetic peptide derivative belonging to the ACE inhibitor class, primarily formulated for oral administration. The classification of Lisinopril as an ACE inhibitor defines its role among agents that target the renin-angiotensin system.

This medication is chemically synthesized, derived from L-Lysine and L-Proline, underscoring its nature as a synthetic compound rather than a naturally sourced substance. The active component is delivered as a single active ingredient product, offered as an oral tablet and occasionally as an oral solution, facilitating its systemic effect after being swallowed.


Lisinopril's Composition and Form

The medication's composition is centered on the active component, Lisinopril, combined with various excipients required for stability and delivery.

A key differentiating feature of Lisinopril is that it is not a prodrug; it is already pharmacologically active upon ingestion and does not require metabolism by the liver to begin working. This means the body can utilize the active compound directly. This direct action characterizes its function as a systemic agent.


General Benefit and Purpose

The overarching benefit of Lisinopril is its ability to reduce the pressure and strain within the circulatory system, thereby easing the burden on the heart. By promoting the relaxation and widening of blood vessels and encouraging the body to excrete excess sodium and water, this ACE inhibitor effectively decreases systemic vascular resistance. This mechanism serves the general purpose of helping the body maintain lower blood pressure and supporting cardiovascular function, which is the foundational therapeutic action for the management of conditions like hypertension.

Regulatory References

  1. Lisinopril DailyMed (NIH/FDA)
  2. Lisinopril Not a Prodrug (NCBI/NIH)
  3. Lisinopril MedlinePlus Drug Info

What side effects are possible with Lithium Chlorid?

Possible Side Effects and Safety Information

The safety profile for the active ingredient, Lisinopril, is categorized by official regulatory bodies into frequency classes and System-Organ Classes (SOCs). This classification structure communicates the potential adverse reactions documented in clinical use and surveillance.

Common reactions—those occurring in 1/100 to < 1/10 of patients—primarily involve the Nervous System and Respiratory systems. These effects include headache, dizziness, and a persistent, dry cough, which is a recognized class effect. Orthostatic effects (a drop in blood pressure upon standing) are also commonly documented.

Reactions classified as Uncommon or Rare include broader systemic effects such as nausea, abdominal pain, rash, and impotence. Serious, clinically significant adverse reactions are specifically highlighted in official labeling, with the most critical being Angioedema, a severe hypersensitivity reaction involving swelling of the face, lips, and throat, which can occur at any time during treatment.

Safety Considerations and Risk Patterns

The label documents specific patterns, noting that excessive hypotension is more likely to occur following the first dose or at the start of dose escalation. Population-specific concerns include a documented higher incidence of Angioedema in Black patients. Furthermore, renal function requires particular caution, as the medicine's elimination pathway may necessitate lower initial doses for older adults and those with existing renal impairment. The risk of hyperkalaemia (high potassium) is a recognized metabolic safety concern.

Overdose and Emergency Response

The official regulatory profile for Lithium Carbonate describes overdose based on a progression of documented clinical signs, primarily affecting the Central Nervous System (CNS) and renal systems. Early manifestations may include gastrointestinal effects (nausea, vomiting, diarrhea) and initial neurological signs such as coarse tremor, mild ataxia, muscle weakness, and drowsiness. Upon the appearance of these documented signs of toxicity, the patient must discontinue the medication immediately and contact a healthcare professional, as stated in the labeling.

The official profile recognizes the potential for severe and life-threatening outcomes. These include seizures, coma, irreversible brain damage (from encephalopathic syndrome), and serious cardiac manifestations (ECG changes). Immediate emergency assistance is required if severe symptoms like fainting, abnormal heart rhythms, or acute changes in mental status occur. No specific antidote for lithium poisoning is known. Management is characterized as supportive, often necessitating specific procedures such as hemodialysis for effective clearance, especially in populations with increased risk, such as the elderly or those with pre-existing renal disease.

Therapeutic Uses of Lithium Chlorid

The therapeutic benefit of Lithium Chloride (or Lithium) is centered on offering crucial symptomatic relief and supportive management across specific domains of mood and emotional stability. It is primarily used to help manage the intensity and burden of pronounced symptoms associated with episodic mood disorders. The medication is indicated for the management of Bipolar Disorder.

Lithium is commonly used across conditions characterized by recurrent or episodic manifestations. This includes the management of acute manic symptoms, long-term support for Bipolar Disorder, and as an adjunct for managing difficult-to-treat depressive symptoms. It helps address symptom clusters that may become intense or disruptive, such as symptoms of increased neurological or muscular activity or noticeable functional strain. This supportive role helps patients cope more steadily and assists with maintaining a sense of stability when symptoms are more noticeable.

“It is applied across domains where additional symptomatic support is needed.”

Quick Fact: Used for Managing Heightened Symptoms

Eligibility and Restrictions for Use

Who Can and Cannot Use Lithium Chlorid? (Lithium)

Official regulatory documents strictly define the patient population eligible for Lithium based on age, organ function, and specific disease states. The medicine is primarily approved for adults and pediatric patients 7 years of age and older for Bipolar I disorder, while its safety is not established for children younger than seven.

Eligibility Restrictions

Category Official Regulatory Status
Contraindicated Populations Patients with Severe Renal Impairment, Brugada Syndrome, Severe Cardiac Disease, Addison's Disease, and Untreated Hypothyroidism.
Pregnancy and Lactation Contraindicated while breastfeeding. During pregnancy, use may cause fetal harm (e.g., cardiac anomalies) and requires careful consideration and monitoring.
Conditional Use Geriatric patients require extreme caution due to increased toxicity risk. Use is also restricted in patients prone to dehydration or sodium depletion, and those taking diuretics or ACE inhibitors.

Eligibility is defined by the necessity of safe clearance; therefore, compromised kidney function or cardiac stability often results in formal non-eligibility as stated in labeling.

What should I know about interactions with other medicines?

The official regulatory interaction profile for Lisinopril is formally structured around contraindicated combinations, pharmacodynamic reinforcement, and altered clearance of co-administered drugs. This information is based on authoritative government documentation.

Classification Official Regulatory Documentation Statement
Contraindicated Combinations Co-administration with Sacubitril/Valsartan is prohibited, requiring a 36-hour mandatory separation period. Combination with Aliskiren is contraindicated for patients with diabetes mellitus.
Exposure-Modifying Agents Co-administration with Lithium results in a formal pharmacokinetic interaction. Lisinopril reduces the renal clearance of Lithium, leading to increased serum Lithium concentrations.
Pharmacodynamic Reinforcement Diuretics (including potassium-sparing agents) and Potassium Supplements increase the documented risk of hyperkalemia and/or hypotension. NSAIDs may diminish the blood pressure-lowering effect and increase renal risk.
Timing Rules Diuretic therapy should be discontinued 2 to 3 days prior to initiating Lisinopril to mitigate the risk of symptomatic hypotension.

The profile details restrictions on product classes such as mTOR inhibitors and NEP inhibitors, which are documented to increase the risk of angioedema. Furthermore, Alcohol (Ethanol) is documented as potentially causing an additive effect in lowering blood pressure. The regulatory information for this drug centers on managing additive effects on blood pressure, potassium balance, and mandatory timing to prevent severe outcomes.

Mechanism of Action

️ Modulating Intracellular Enzyme Activity

Lithium acts primarily by inhibiting two crucial enzymes: glycogen synthase kinase-3 (GSK-3) and inositol monophosphatase (IMPase). This mechanism disrupts the inositol signaling cycle and modulates the Wnt pathway, modulating excessive or dysregulated cellular communication within the brain. The inhibition of these enzymes influences signaling within the central nervous system, which contributes to the drug’s profile of systemic physiological modulation.

️ Influencing Neuronal Structure and Survival

Through the modulation of the Wnt/beta-catenin pathway, mediated by the inhibition of GSK-3, the drug alters the expression of certain neurotrophic factors and protective cellular proteins. This interaction influences pathways that govern cell fate, modulating mechanisms that determine apoptosis (programmed cell death) versus cellular survival. This action contributes to increased neuronal survival and modulates the structural components of neural circuits, supporting the function of communication pathways over time.

Adjusting Synaptic Neurotransmitter Activity

The medication functions as a broad modulator across several neurotransmitter systems, including those involving dopamine and serotonin, altering both their release and receptor sensitivity. This collective activity influences the regulation of information transfer between nerve cells.

Dosage and Administration Information

How to Use Lithium Carbonate

The usage of Lithium Carbonate (referred to as Lithium Chlorid) is characterized by a precise, highly monitored oral regimen.

Administration Scope and Form

Feature Detail
Route of administration The medicine is administered exclusively by the oral route.
Available Forms Immediate-Release (IR) and Extended-Release (ER) tablets, as well as an oral solution, are available forms.
Dosing Frequency The total daily dose is typically administered in two to three divided doses to help maintain stable drug levels.

Dosage and Monitoring Protocol

The core usage pattern involves dose titration based on measured drug levels in the bloodstream. The dose is adjusted to achieve a target therapeutic concentration, generally in the range of 0.6 to 1.2 mEq/L. During the acute phase, serum levels are typically monitored frequently (e.g., twice weekly), with maintenance monitoring occurring less often, such as every two months. Blood samples for this testing are drawn 8 to 12 hours after the last dose (trough level) to ensure accurate concentration measurement.

Contextual Administration Instructions

To facilitate proper use, the medicine is generally taken with food to minimize gastrointestinal discomfort. Furthermore, a key aspect of treatment is the importance of maintaining a consistent, adequate intake of fluid and salt throughout the entire course of therapy. Specific handling applies to extended-release tablets, which are swallowed whole and are not to be crushed, chewed, or divided. If a scheduled dose is missed, the protocol involves skipping it entirely and taking the next dose at the regular time, rather than doubling the dose.

Recent Clinical Evidence

The research evidence for the active ingredient, Lithium, primarily was studied for its role in research exploring conditions characterized by fluctuating or episodic manifestations, such as Bipolar Disorder. Studies have been conducted across different phases of the condition to understand the patterns observed in short-term symptom activity and long-term stability.


Evidence for Use in Bipolar Disorder Prophylaxis

Research utilizes structured, long-term study designs, mainly Randomized Controlled Trials (RCTs) and Systematic Reviews, to monitor the primary outcome of risk of recurrence of mood episodes (manic and depressive phases). Research examined the risk of recurrence and reported patterns observed in the studied populations. Studies have reported differences in evidence consistency between manic episode prevention and depressive episode prevention, with consistency described as less robust for depressive episodes. Long-term follow-up durations for many RCTs were limited to one or two years.

Evidence for Acute Episode Management and Research on Suicidal Behavior

Research studies explored short-term symptom changes during periods of heightened symptom activity, specifically focusing on acute manic symptoms. These short-term RCTs typically measured changes in the intensity of manic symptoms, and the medicine was often studied in combination protocols. A separate area of research examined suicidal behavior. This evidence was derived from long-term observational studies and meta-analyses, exploring patterns related to the occurrence of suicidal self-directed violence. Evidence is limited regarding the measured outcomes when used as monotherapy for acute bipolar depression.

Long-Term Study and Durability of Follow-up

Long-term research has explored how symptoms change over time using Prospective Cohort Studies, extending beyond the short-to-intermediate follow-up durations of RCTs. These studies monitored outcomes related to functional imbalance and overall stability. However, the available long-term outcomes are not fully established by the same depth of randomized evidence available for short-term effects.

Evidence in Specific Patient Groups and Subtypes

The research base has explored outcomes in specific subgroups, including individuals with rapid-cycling illness or mixed states. Studies reported patterns that varied across trials for these groups. Data for other groups, such as children or pregnant individuals, remain insufficient for comparison.

What is Still Uncertain in the Research Record

The comprehensive research highlights that evidence consistency is lower for preventing the depressive phase compared to the manic phase. Subgroup findings are uncertain for specific illness patterns. Furthermore, long-term effects are not fully established by highly controlled, randomized trials, as much of the extended data was derived from observational settings.

Frequently Asked Questions (FAQ)

Common questions about Lithium Chlorid (FAQ)

Q: Can Lithium Chlorid affect kidney function long-term?

Regulatory documents state that chronic lithium therapy is associated with structural changes in the kidneys and a reduction in the kidney’s ability to concentrate urine. This can sometimes lead to polyuria (increased urination) or nephrogenic diabetes insipidus. Regulatory labeling emphasizes that kidney function is monitored prior to and during treatment.

Q: What happens if a dose of Lithium Chlorid is missed?

Official guidance instructs users not to double the next dose if one is missed. The instruction is to skip the missed dose entirely and take the next scheduled dose at the regular time. Questions regarding a missed dose should be directed to a healthcare provider.

Q: Can chronic use of Lithium Chlorid cause thyroid problems like hypothyroidism?

Official information indicates that taking lithium is associated with both hypothyroidism (underactive thyroid) and, less commonly, hyperthyroidism (overactive thyroid). Because of this association, regulatory information highlights that thyroid function is monitored regularly during treatment.

Q: How does a low-sodium diet influence the effects of Lithium Chlorid?

Changes in your sodium intake, such as following a low-sodium diet, can increase the amount of lithium in your bloodstream, thereby raising the risk of lithium toxicity. Regulatory documents note that maintaining a consistent intake of salt and adequate hydration is essential to the safe use of the medicine.

Q: Does alcohol consumption affect the safety or effectiveness of Lithium Chlorid?

Alcohol consumption can intensify the central nervous system side effects of lithium, such as dizziness and drowsiness. This combination may also impair thinking and judgment. Official warnings suggest that the use of alcohol should generally be discussed with a healthcare provider.

Q: Does Lithium Chlorid need to be taken with food?

Lithium may cause minor gastrointestinal discomfort, such as nausea, especially when starting treatment. Official product information suggests that this discomfort may be reduced by taking the medication concomitantly with food.

Q: Why was Lithium Chlorid once used as a salt substitute?

Historically, lithium chloride was marketed as a salt substitute for people who needed to limit their sodium intake for conditions like high blood pressure. However, its use was later prohibited by governmental bodies due to numerous reports of lithium toxicity in the late 1940s.

Q: What is the difference between Lithium Chlorid and table salt (sodium chloride)?

While both are salts, they are fundamentally different in their use and effect on the body. Lithium is a mood stabilizer used in medicine, whereas sodium chloride (table salt) is an essential dietary electrolyte. Regulatory warnings confirm that changes in the amount of sodium chloride in the diet can directly and significantly affect the concentration of lithium in the blood.

Q: What are the most common side effects of taking Lithium Chlorid?

According to official adverse reaction data, common side effects in adults can include a fine hand tremor, increased urination (polyuria), mild thirst, nausea, and general discomfort. These are often transient, meaning they may be more noticeable when treatment begins.

Q: Are weight gain or changes in appetite a common side effect of Lithium Chlorid?

Official product information reports decreased appetite as a possible adverse reaction. Furthermore, long-term use of lithium is associated with weight gain in some patients, though the exact cause is variable.

Q: Can Lithium Chlorid cause a dry mouth or increased thirst?

Yes, increased thirst (polydipsia) is listed in regulatory documents as a common adverse reaction that may persist throughout treatment. Dry mouth is also listed as a possible side effect.

Q: Is it normal to experience a slight hand tremor when starting Lithium Chlorid?

Yes, a fine hand tremor is a common and reported adverse reaction. This side effect may occur when starting the medication and can sometimes continue throughout the course of treatment.

Q: What are the signs of having too much Lithium Chlorid in the blood?

Early signs of lithium toxicity include diarrhea, vomiting, drowsiness, muscular weakness, and lack of coordination. As toxicity progresses, more severe signs may include giddiness, blurred vision, or slurred speech.

Q: Does Lithium Chlorid interact with common over-the-counter pain relievers?

Yes, caution is advised regarding the combination of lithium with Nonsteroidal Anti-inflammatory Drugs (NSAIDs), which include common pain relievers like ibuprofen. Regulatory warnings state that NSAIDs can significantly increase the concentration of lithium in the blood, leading to a risk of toxicity. Regulatory information states that serum lithium levels must be closely monitored when an NSAID is started or stopped.

Q: Can taking diuretics (water pills) affect the level of Lithium Chlorid in the body?

Yes, caution should be exercised when combining lithium with diuretics (water pills). Regulatory documents note that the sodium loss caused by diuretics can reduce how quickly the kidneys eliminate lithium, which in turn elevates the concentration of lithium in the bloodstream and increases the risk of toxicity.

Q: Is there a risk when combining Lithium Chlorid with SSRI antidepressants?

The combination of lithium with serotonergic agents, which include SSRI antidepressants, carries a risk of a serious, potentially life-threatening problem called Serotonin Syndrome. Symptoms can include rapid heart rate, changes in mental status, and high body temperature, and must be managed under medical supervision.

Q: What conditions make someone more sensitive to the side effects of Lithium Chlorid?

Official labeling identifies several conditions that increase the risk of lithium toxicity. These include impaired renal (kidney) function, volume depletion or dehydration, fever, and existing cardiovascular disease. Any factor that leads to volume depletion may raise the lithium level in the body.

Q: What is the connection between Lithium Chlorid and diabetes insipidus?

Official product information notes that long-term lithium treatment can be associated with a reduced ability of the kidneys to concentrate urine. This can sometimes present as nephrogenic diabetes insipidus, a condition characterized by excessive thirst and the production of a large amount of dilute urine.

Q: Can dehydration cause a sudden increase in the effects or toxicity of Lithium Chlorid?

Yes, volume depletion or dehydration is listed in regulatory documents as a factor that significantly increases the risk of lithium toxicity. This is because the lack of fluid can increase the concentration of lithium in your blood to dangerous levels.

Q: What precautions should be taken in hot weather or during prolonged exercise while on Lithium Chlorid?

Official guidance suggests avoiding overheating or becoming dehydrated during exercise or in hot weather. It is noted that adequate hydration requires following a healthcare provider's instructions regarding fluid intake.

Q: What kind of vision problems could be linked to Lithium Chlorid use?

Official adverse event reports list blurred vision as a reported sign of moderate lithium toxicity. Furthermore, lithium use has been linked to Pseudotumor Cerebri (a condition involving increased pressure around the brain), which can also cause vision changes.

Q: Is Lithium Chlorid a medication that can cause a serious allergic reaction?

Yes, like many medications, regulatory documents state that lithium is contraindicated (should not be used) in patients who have a known hypersensitivity (allergic reaction) to any of the inactive ingredients found in the drug product.

Q: Is there evidence that Lithium Chlorid helps prevent suicidal behavior?

Studies have specifically examined patterns related to suicidal behavior in patients taking lithium. The medication is often used for conditions associated with a high risk of self-directed violence, according to the research evidence overview.

Q: Does Lithium Chlorid have effects on muscle strength or physical energy levels?

Official reports indicate that muscular weakness and a lack of coordination (ataxia) can be early signs of lithium toxicity. Additionally, fatigue (tiredness) is reported as a general adverse reaction associated with the medication.

Q: Can Lithium Chlorid affect blood pressure?

Official adverse event reports list hypotension (low blood pressure) and peripheral circulatory collapse as potential cardiovascular adverse reactions associated with lithium treatment.

Q: Is it necessary to maintain a consistent fluid intake while on this medication?

Regulatory documents note that maintaining a consistent and adequate fluid intake is essential to help prevent volume depletion, which can increase the risk of lithium toxicity.

Q: Are the symptoms of Lithium Chlorid toxicity the same for everyone?

Official warnings note that some patients may be abnormally sensitive to lithium and could exhibit signs of toxicity even at serum concentrations that are generally considered within the safe therapeutic range. This emphasizes the importance of monitoring individual responses.

Q: How is Lithium Chlorid processed and eliminated by the body?

According to the clinical pharmacology profile, lithium is primarily eliminated from the body through the urine. The rate at which the kidneys excrete lithium is proportional to its concentration in the plasma, and it has an elimination half-life of about 24 hours.

Q: Can Lithium Chlorid cause memory or concentration issues?

Reported adverse reactions affecting the central nervous system include confusion, somnolence (drowsiness), and psychomotor retardation. These effects may manifest as issues with memory or concentration in some patients.

Q: What is the difference between acute and chronic Lithium Chlorid toxicity?

Acute toxicity generally occurs following a single high-dose exposure and often involves initial gastrointestinal symptoms like vomiting. Chronic toxicity results from a slower build-up of the drug over time and is more typically associated with severe nervous system effects, such as movement disorders.

Q: Is there a link between Lithium Chlorid and hair loss?

Official adverse reaction data includes alopecia (drying and thinning of hair) as a reported dermatologic side effect associated with the use of lithium.

Q: Can Lithium Chlorid be used to treat major depressive disorder alone?

Lithium is officially approved for the treatment of Bipolar I Disorder (both manic episodes and maintenance treatment). Specific indications for using it as a monotherapy (by itself) for major depressive disorder are not included in the primary regulatory labeling.

Q: What should be done if stomach issues like severe nausea or diarrhea occur while on Lithium Chlorid?

Official guidance states that if signs of lithium toxicity occur—such as severe diarrhea, vomiting, tremor, and muscular weakness—the therapy should be discontinued, and a physician should be contacted.

Q: Are there specific warnings for people with heart conditions who consider taking Lithium Chlorid?

Regulatory information advises that lithium should generally not be given to patients with significant cardiovascular disease and is specifically contraindicated for patients with Brugada Syndrome. The medication has been associated with reported adverse reactions like cardiac arrhythmias.

Q: What is the general mechanism by which Lithium affects brain substances?

The exact mechanism of action is not entirely known, but official information suggests it is related to the drug's ability to alter the reuptake and metabolism of monoamines like norepinephrine and serotonin. It is also thought to influence certain internal cell signaling systems.

Q: How does the narrow therapeutic index of Lithium Chlorid affect its use?

Lithium has a narrow therapeutic index, meaning the dose needed to be effective is very close to the dose that can cause toxicity. Because of this, the official warning highlights that careful dosage control and regular blood monitoring are necessary to keep the concentration stable and prevent harm.

Q: What should I know about taking Lithium Chlorid if I have a history of a seizure disorder?

Official adverse reaction reports list epileptiform seizures and blackout spells as potential central nervous system adverse reactions associated with the use of lithium.

How should Lithium Chlorid be stored and disposed of?

Storage and Disposal Requirements for Lithium Chloride

Official regulatory information defines specific conditions for storing and disposing of Lithium Chloride to ensure stability and safety.

Storage Conditions

Requirement Type Official Guidance
Temperature & Environment Store in a cool and dry place, typically between 15–25 °C. Must be protected from freezing and direct sunlight.
Container & Safety Keep the container tightly closed to protect from moisture. Store out of the reach of children.

Disposal Instructions

The product and its container must be disposed of in accordance with local, national, and international regulations. It is strictly prohibited from being released into the environment, including into drains, sewers, or waterways.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lithium Chlorid found in:

A-Z Index: